Correction: Dermatol Ther (Heidelb) (2025) 15:2015–2029 10.1007/s13555-025-01470-7
In this article, the text in abstract which current reads:
Gene expression profiling (GEP) is a tool that offers prognostic information to help assess metastatic risk and guide treatment decisions; however, prospective, nonbiased studies are needed to validate its utility to support broader integration into clinical practice.
However the text should read:
Gene expression profiling (GEP) is an established prognostic tool to assess the likelihood of metastasis and guide treatment decisions.
The below line under “Gene Expression Profiling (GEP)” to be deleted.
While it shows promise as a prognostic tool, further prospective and unbiased research is needed to support widespread implementation into clinical practice.
The original article has been corrected.
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.